News

FutureNeuro granted €3.9mill funding for BESTS project

Epilepsy Ireland would like to congratulate our colleagues in FutureNeuro after it was confirmed that €3.9mill has been awarded for their Blockchain & AI-Enabled Stratified Trial System (BESTS) project.

Funding was granted under the Disruptive Technology Innovation Fund (DTIF) which is run by the Department of Business, Enterprise and Innovation.

New study finds that Epidyolex has positive impact on seizure frequency in TSC

New data regarding the use of Epidyolex (Cannabiniol) in the treatment of the rare condition tuberous sclerosis complex (TSC) has pointed to the use of the product having a positive impact in seizure frequency for the patients included in the trial.

The findings of the study were presented recently at the annual meeting of the American Epilepsy Society.

Updated: Disney issue warning to those or those with photosensitive epilepsy about seizure risk in the Rise of Skywalker.

Further to our most recent news update regarding Disney issuing a warning to those with photosensitive epilepsy in relation to the latest instalment in the Star Wars franchise, the Irish Film Classification Office have responded to Epilepsy Ireland's query regarding their plans in this regard.

Dr. John Lynch - RIP.

Epilepsy Ireland would like to express our sincere condolences to the family, friends, colleagues and patients of the late Dr. John Lynch on his untimely passing.

Our thoughts in particular are with his wife Louise and children, Danny and Katie.

Research Funding Scheme

We’ve just closed our 2019/20 Research Funding scheme call for applications, and we are delighted to have received a record 16 applications for funding.

Applications address a wide range of topics including SUDEP, Cannabidiol in epilepsy, potential genetics causes and treatments, intellectual disability, mental health in epilepsy, maternal health in epilepsy, seizure detection devices, neonatal seizures, the impact of epilepsy, medication safety and more.